Site-Identification by Ligand Competitive Saturation (SILCS) assisted pharmacophore modeling. 2014

Wenbo Yu, and Sirish Kaushik Lakkaraju, and E Prabhu Raman, and Alexander D MacKerell
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD, 21201, USA.

Database screening using receptor-based pharmacophores is a computer-aided drug design technique that uses the structure of the target molecule (i.e. protein) to identify novel ligands that may bind to the target. Typically receptor-based pharmacophore modeling methods only consider a single or limited number of receptor conformations and map out the favorable binding patterns in vacuum or with a limited representation of the aqueous solvent environment, such that they may suffer from neglect of protein flexibility and desolvation effects. Site-Identification by Ligand Competitive Saturation (SILCS) is an approach that takes into account these, as well as other, properties to determine 3-dimensional maps of the functional group-binding patterns on a target receptor (i.e. FragMaps). In this study, a method to use the FragMaps to automatically generate receptor-based pharmacophore models is presented. It converts the FragMaps into SILCS pharmacophore features including aromatic, aliphatic, hydrogen-bond donor and acceptor chemical functionalities. The method generates multiple pharmacophore hypotheses that are then quantitatively ranked using SILCS grid free energies. The pharmacophore model generation protocol is validated using three different protein targets, including using the resulting models in virtual screening. Improved performance and efficiency of the SILCS derived pharmacophore models as compared to published docking studies, as well as a recently developed receptor-based pharmacophore modeling method is shown, indicating the potential utility of the approach in rational drug design.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D016000 Cluster Analysis A set of statistical methods used to group variables or observations into strongly inter-related subgroups. In epidemiology, it may be used to analyze a closely grouped series of events or cases of disease or other health-related phenomenon with well-defined distribution patterns in relation to time or place or both. Clustering,Analyses, Cluster,Analysis, Cluster,Cluster Analyses,Clusterings

Related Publications

Wenbo Yu, and Sirish Kaushik Lakkaraju, and E Prabhu Raman, and Alexander D MacKerell
March 2021, Journal of pharmaceutical sciences,
Wenbo Yu, and Sirish Kaushik Lakkaraju, and E Prabhu Raman, and Alexander D MacKerell
January 2015, Methods in molecular biology (Clifton, N.J.),
Wenbo Yu, and Sirish Kaushik Lakkaraju, and E Prabhu Raman, and Alexander D MacKerell
April 2011, Journal of chemical information and modeling,
Wenbo Yu, and Sirish Kaushik Lakkaraju, and E Prabhu Raman, and Alexander D MacKerell
January 2021, Molecules (Basel, Switzerland),
Wenbo Yu, and Sirish Kaushik Lakkaraju, and E Prabhu Raman, and Alexander D MacKerell
July 2009, PLoS computational biology,
Wenbo Yu, and Sirish Kaushik Lakkaraju, and E Prabhu Raman, and Alexander D MacKerell
May 2023, Journal of chemical theory and computation,
Wenbo Yu, and Sirish Kaushik Lakkaraju, and E Prabhu Raman, and Alexander D MacKerell
January 2022, New journal of chemistry = Nouveau journal de chimie,
Wenbo Yu, and Sirish Kaushik Lakkaraju, and E Prabhu Raman, and Alexander D MacKerell
September 2022, Chemistry (Basel, Switzerland),
Wenbo Yu, and Sirish Kaushik Lakkaraju, and E Prabhu Raman, and Alexander D MacKerell
May 2023, Molecular pharmaceutics,
Wenbo Yu, and Sirish Kaushik Lakkaraju, and E Prabhu Raman, and Alexander D MacKerell
July 2021, Chemical science,
Copied contents to your clipboard!